Half-Life Cancer Research Results
Half-Life, Half-Life: Click to Expand ⟱
| Source: |
| Type: |
For many drugs, the half-life is the time it takes for half of the drug’s active substance to be eliminated from the bloodstream.
In medicine, knowing a drug’s half-life helps in designing treatment regimens that reduce adverse effects.
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
Apoptosis↑, *Inflam↓, TLR4↓, NF-kB↓, *GutMicro↑, mtDam↑, *ROS↓, Casp1↑, TNF-α↑, Bcl-2↓, PARP↓, MMP↓, Cyt‑c↓, Casp3↑, TumVol↓, COX2↓, iNOS↓, ROS↑, selectivity↑, TumCMig↓, TumCI↓, ER Stress↑, PERK↑, eIF2α↑, ATF4↑, CHOP/DDIT3↑, TumCCA↑, cycD1/CCND1↓, P21↓, P53↑, BioAv↝, Half-Life↝,
Apoptosis↑, Casp↑, Dose↝, OS↑, *Inflam↓, *AntiThr↑, *antiOx↑, *Half-Life↝, TumCG↓,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
Hif1a↓, ROS↓, mTOR↓, p70S6↓, 4E-BP1↓, eIF2α↓, TumCCA↑, TumCP↓, Half-Life↝,
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27/CDKN1B↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↓, 1, ROS↑, 1, ROS⇅, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1, mtDam↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
cMyc↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↑, 3, BAX↑, 1, Bcl-2↓, 1, Bcl-2↑, 1, Casp↑, 1, Casp1↑, 1, Casp3↑, 2, Casp7↑, 1, Casp9↑, 1, Cyt‑c↓, 1, iNOS↓, 1, JNK↑, 1, p27/CDKN1B↑, 1, p38↑, 1, survivin↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
p70S6↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1, eIF2α↓, 1, eIF2α↑, 1, ER Stress↑, 1, PERK↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, PARP↓, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 2, P21↓, 1, P21↑, 1, TumCCA↑, 3,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
4E-BP1↓, 1, EMT↓, 1, ERK↓, 1, GSK‐3β↓, 1, mTOR↓, 2, PI3K↓, 1, PTEN↑, 1, STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
E-cadherin↓, 1, MMPs↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 2, TumMeta↓, 1, Twist↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↑, 1, ATF4↑, 1, Hif1a↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, NF-kB↓, 1, p‑NF-kB↑, 1, TLR4↓, 1, TNF-α↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 1, Dose↝, 1, Half-Life↝, 2, selectivity↑, 2,
Functional Outcomes(tgid=23) ⓘ
chemoP↑, 1, OS↑, 1, TumVol↓, 1,
Total Targets: 69
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, Catalase↑, 1, GPx↑, 1, GSTA1↑, 1, ROS↓, 1, SOD↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 1,
Migration(tgid=13) ⓘ
MMP13↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, IL1β↓, 1, Inflam↓, 3, PGE2↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, Half-Life↝, 2,
Clinical Biomarkers(tgid=22) ⓘ
GutMicro↑, 1,
Functional Outcomes(tgid=23) ⓘ
hepatoP↑, 1,
Total Targets: 16
Scientific Paper Hit Count for: Half-Life, Half-Life
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:1109 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page